The DOI matches its Crossref record; 409 of the 409 references it cites were found in a registry or an index.
Host-Directed Antiviral Therapy
Open accessAbstract
Antiviral drugs have traditionally been developed by directly targeting essential viral components. However, this strategy often fails due to the rapid generation of drug-resistant viruses. Recent genome-wide approaches, such as those employing small interfering RNA (siRNA) or clustered regularly interspaced short palindromic repeats (CRISPR) or those using small molecule chemical inhibitors targeting the cellular “kinome,” have been used successfully to identify cellular factors that can support virus replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,796
Sohrabi, C., Alsafi, Z., O'Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Iosifidis, C., & Agha, R. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.02.034 · Cited by 6,069
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Shepherd, F. A., Rodrigues Pereira, J., Ciuleanu, T., Tan, E. H., Hirsh, V., Thongprasert, S., Campos, D., Maoleekoonpiroj, S., Smylie, M., Martins, R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050753 · Cited by 5,419
DNA methylation and its basic function
Moore, L. D., Le, T., & Fan, G. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.112 · Cited by 4,906
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,066
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940 · cited 1×
“rienced a cytokine storm were elderly or had compromised immune systems (219).”
BackgroundA Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
The roles of TLRs, RLRs and NLRs in pathogen recognition
Kawai, T., & Akira, S. (2009) · International Immunology · doi:10.1093/intimm/dxp017 · Cited by 1,670
The Sequence of the Human Genome
Venter, J. C., Smith, H. O., & Adams, M. D. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.237016 · Cited by 1,648
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology
Forgac, M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2272 · Cited by 1,619
Distinguishing between resistance, tolerance and persistence to antibiotic treatment
Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.34 · Cited by 1,612
Roulois, D., Loo Yau, H., Singhania, R., Wang, Y., Danesh, A., Shen, S. Y., Han, H., Liang, G., Jones, P. A., Pugh, T. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.056 · Cited by 1,527
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Brass, A. L., Huang, I.-C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.017 · Cited by 1,269
Antibiotic tolerance facilitates the evolution of resistance
Levin-Reisman, I., Ronin, I., Gefen, O., Braniss, I., Shoresh, N., & Balaban, N. Q. (2017) · Science · doi:10.1126/science.aaj2191 · Cited by 1,251
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wölk, B., Hatziioannou, T., McKeating, J. A., Bieniasz, P. D., & Rice, C. M. (2007) · Nature · doi:10.1038/nature05654 · Cited by 1,232
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R., & Vitelli, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf529 · Cited by 1,177
COVID-19: what is next for public health?
Heymann, D. L., & Shindo, N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30374-3 · Cited by 1,138
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J., & Cantor, H. (2000) · Science · doi:10.1126/science.287.5454.860 · Cited by 1,125
King, A. M. Q., Lefkowitz, E. J., Mushegian, A. R., Adams, M. J., Dutilh, B. E., Gorbalenya, A. E., Harrach, B., Harrison, R. L., Junglen, S., Knowles, N. J., et al. (2018) · Archives of Virology · doi:10.1007/s00705-018-3847-1 · Cited by 1,078
DNA methyltransferase Dnmt1 associates with histone deacetylase activity
Fuks, F., Burgers, W. A., Brehm, A., Hughes-Davies, L., & Kouzarides, T. (2000) · Nature Genetics · doi:10.1038/71750 · Cited by 994
Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M. C., Irelan, J. T., Chiang, C.-Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.032 · Cited by 960
CD69: from activation marker to metabolic gatekeeper
Cibrián, D., & Sánchez‐Madrid, F. (2017) · European Journal of Immunology · doi:10.1002/eji.201646837 · Cited by 948
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Ploss, A., Evans, M. J., Gaysinskaya, V. A., Panis, M., You, H., de Jong, Y. P., & Rice, C. M. (2009) · Nature · doi:10.1038/nature07684 · Cited by 941
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Hyun Kim, J., Halfmann, P., Hatta, M., et al. (2007) · Nature · doi:10.1038/nature05495 · Cited by 934
Human host factors required for influenza virus replication
König, R., Stertz, S., Zhou, Y., Inoue, A., Hoffmann, H. H., Bhattacharyya, S., Alamares, J. G., Tscherne, D. M., Ortigoza, M. B., Liang, Y., et al. (2010) · Nature · doi:10.1038/nature08699 · Cited by 813
Genome-Scale RNAi Screen for Host Factors Required for HIV Replication
Zhou, H., Xu, M., Huang, Q., Gates, A. T., Zhang, X. D., Castle, J. C., Stec, E., Ferrer, M., Strulovici, B., Hazuda, D. J., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.10.004 · Cited by 789
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Velu, V., Titanji, K., Zhu, B., Husain, S., Pladevega, A., Lai, L., Vanderford, T. H., Chennareddi, L., Silvestri, G., Freeman, G. J., et al. (2009) · Nature · doi:10.1038/nature07662 · Cited by 771
Fatty acid metabolism: Target for metabolic syndrome
Wakil, S. J., & Abu-Elheiga, L. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800079-jlr200 · Cited by 731
Lupberger, J., Zeisel, M. B., Xiao, F., Thumann, C., Fofana, I., Zona, L., Davis, C., Mee, C. J., Turek, M., Gorke, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2341 · Cited by 706
Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication
Karlas, A., Machuy, N., Shin, Y., Pleissner, K.-P., Artarini, A., Heuer, D., Becker, D., Khalil, H., Ogilvie, L. A., Hess, S., et al. (2010) · Nature · doi:10.1038/nature08760 · Cited by 695
Fellay, J., Marzolini, C., Meaden, E. R., Back, D. J., Buclin, T., Chave, J.-P., Decosterd, L. A., Furrer, H., Opravil, M., Pantaleo, G., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07276-8 · Cited by 658
Jänne, P. A., Shaw, A. T., Pereira, J. R., Jeannin, G., Vansteenkiste, J., Barrios, C., Franke, F. A., Grinsted, L., Zazulina, V., Smith, P., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70489-8 · Cited by 655
A Physical and Regulatory Map of Host-Influenza Interactions Reveals Pathways in H1N1 Infection
Shapira, S. D., Gat-Viks, I., Shum, B. O. V., Dricot, A., de Grace, M. M., Wu, L., Gupta, P. B., Hao, T., Silver, S. J., Root, D. E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.018 · Cited by 635
Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations
Fridman, O., Goldberg, A., Ronin, I., Shoresh, N., & Balaban, N. Q. (2014) · Nature · doi:10.1038/nature13469 · Cited by 613
Innate and Adaptive Immune Memory: an Evolutionary Continuum in the Host’s Response to Pathogens
Netea, M. G., Schlitzer, A., Placek, K., Joosten, L. A. B., & Schultze, J. L. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2018.12.006 · Cited by 599
Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans
Hagan, T., Cortese, M., Rouphael, N., Boudreau, C., Linde, C., Maddur, M. S., Das, J., Wang, H., Guthmiller, J., Zheng, N.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.010 · Cited by 572
Immune checkpoint blockade in infectious diseases
Wykes, M. N., & Lewin, S. R. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.112 · Cited by 570
Heaton, N. S., Perera, R., Berger, K. L., Khadka, S., LaCount, D. J., Kuhn, R. J., & Randall, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010811107 · Cited by 566
Histone Deacetylase Inhibitors
Miller, T. A., Witter, D. J., & Belvedere, S. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0303094 · Cited by 530
CD4+CD25+ T Cells Regulate Virus-specific Primary and Memory CD8+ T Cell Responses
Suvas, S., Kumaraguru, U., Pack, C. D., Lee, S., & Rouse, B. T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030171 · Cited by 527
Self-citationInfluenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade
Pleschka, S., Wolff, T., Ehrhardt, C., Hobom, G., Planz, O., Rapp, U. R., & Ludwig, S. (2001) · Nature Cell Biology · doi:10.1038/35060098 · Cited by 526
Viral hijacking of cellular metabolism
Thaker, S. K., Ch’ng, J., & Christofk, H. R. (2019) · BMC Biology · doi:10.1186/s12915-019-0678-9 · Cited by 526
RNA interference screen for human genes associated with West Nile virus infection
Krishnan, M. N., Ng, A., Sukumaran, B., Gilfoy, F. D., Uchil, P. D., Sultana, H., Brass, A. L., Adametz, R., Tsui, M., Qian, F., et al. (2008) · Nature · doi:10.1038/nature07207 · Cited by 516
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
Barrows, N. J., Campos, R. K., Powell, S. T., Prasanth, K. R., Schott-Lerner, G., Soto-Acosta, R., Galarza-Muñoz, G., McGrath, E. L., Urrabaz-Garza, R., Gao, J., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.004 · Cited by 497
Drug development in the era of precision medicine
Dugger, S. A., Platt, A., & Goldstein, D. B. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.226 · Cited by 493
mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
Donnelly, R. P., Loftus, R. M., Keating, S. E., Liou, K. T., Biron, C. A., Gardiner, C. M., & Finlay, D. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401558 · Cited by 485
DNA methylation and chromatin – unraveling the tangled web
Robertson, K. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205609 · Cited by 471
Sainz, B., Barretto, N., Martin, D. N., Hiraga, N., Imamura, M., Hussain, S., Marsh, K. A., Yu, X., Chayama, K., Alrefai, W. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2581 · Cited by 452
Chromatin control of herpes simplex virus lytic and latent infection
Knipe, D. M., & Cliffe, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1794 · Cited by 444
Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo
Isogawa, M., Robek, M. D., Furuichi, Y., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7269-7272.2005 · Cited by 442
Bachman, K. E., Rountree, M. R., & Baylin, S. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104661200 · Cited by 438
TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection
Aldridge, J. R., Moseley, C. E., Boltz, D. A., Negovetich, N. J., Reynolds, C., Franks, J., Brown, S. A., Doherty, P. C., Webster, R. G., & Thomas, P. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900655106 · Cited by 425
Drosophila RNAi screen identifies host genes important for influenza virus replication
Hao, L., Sakurai, A., Watanabe, T., Sorensen, E., Nidom, C. A., Newton, M. A., Ahlquist, P., & Kawaoka, Y. (2008) · Nature · doi:10.1038/nature07151 · Cited by 425
A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus Replication
Tai, A. W., Benita, Y., Peng, L. F., Kim, S.-S., Sakamoto, N., Xavier, R. J., & Chung, R. T. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.02.001 · Cited by 422
Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens
Marceau, C. D., Puschnik, A. S., Majzoub, K., Ooi, Y. S., Brewer, S. M., Fuchs, G., Swaminathan, K., Mata, M. A., Elias, J. E., Sarnow, P., et al. (2016) · Nature · doi:10.1038/nature18631 · Cited by 411
Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo
Blattman, J. N., Grayson, J. M., Wherry, E. J., Kaech, S. M., Smith, K. A., & Ahmed, R. (2003) · Nature Medicine · doi:10.1038/nm866 · Cited by 396
Gale, M., & Katze, M. G. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00165-4 · Cited by 387
Multifaceted roles for lipids in viral infection
Heaton, N. S., & Randall, G. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.03.007 · Cited by 381
Evaluation of Combination Chemotherapy
Zhao, L., Wientjes, M. G., & Au, J. L.-S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1087 · Cited by 379
Herold, S., Steinmueller, M., von Wulffen, W., Cakarova, L., Pinto, R., Pleschka, S., Mack, M., Kuziel, W. A., Corazza, N., Brunner, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080201 · Cited by 376
Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice
Szretter, K. J., Gangappa, S., Lu, X., Smith, C., Shieh, W.-J., Zaki, S. R., Sambhara, S., Tumpey, T. M., & Katz, J. M. (2007) · Journal of Virology · doi:10.1128/jvi.02336-06 · Cited by 374
The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense
Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A., & O'Neill, L. A. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021652 · Cited by 370
A CRISPR screen defines a signal peptide processing pathway required by flaviviruses
Zhang, R., Miner, J. J., Gorman, M. J., Rausch, K., Ramage, H., White, J. P., Zuiani, A., Zhang, P., Fernandez, E., Zhang, Q., et al. (2016) · Nature · doi:10.1038/nature18625 · Cited by 369
Discovery of insect and human dengue virus host factors
Sessions, O. M., Barrows, N. J., Souza-Neto, J. A., Robinson, T. J., Hershey, C. L., Rodgers, M. A., Ramirez, J. L., Dimopoulos, G., Yang, P. L., Pearson, J. L., et al. (2009) · Nature · doi:10.1038/nature07967 · Cited by 364
Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics
Savidis, G., McDougall, W. M., Meraner, P., Perreira, J. M., Portmann, J. M., Trincucci, G., John, S. P., Aker, A. M., Renzette, N., Robbins, D. R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.028 · Cited by 363
Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1
Herker, E., Harris, C., Hernandez, C., Carpentier, A., Kaehlcke, K., Rosenberg, A. R., Farese, R. V., & Ott, M. (2010) · Nature Medicine · doi:10.1038/nm.2238 · Cited by 350
Westby, M., Smith-Burchnell, C., Mori, J., Lewis, M., Mosley, M., Stockdale, M., Dorr, P., Ciaramella, G., & Perros, M. (2007) · Journal of Virology · doi:10.1128/jvi.02006-06 · Cited by 350
Walker, P. J., Siddell, S. G., Lefkowitz, E. J., Mushegian, A. R., Dempsey, D. M., Dutilh, B. E., Harrach, B., Harrison, R. L., Hendrickson, R. C., Junglen, S., et al. (2019) · Archives of Virology · doi:10.1007/s00705-019-04306-w · Cited by 341
N6-methyladenosine–encoded epitranscriptomics
Liu, N., & Pan, T. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3162 · Cited by 338
Westby, M., Lewis, M., Whitcomb, J., Youle, M., Pozniak, A. L., James, I. T., Jenkins, T. M., Perros, M., & van der Ryst, E. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4909-4920.2006 · Cited by 337
A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors
Park, R. J., Wang, T., Koundakjian, D., Hultquist, J. F., Lamothe-Molina, P., Monel, B., Schumann, K., Yu, H., Krupzcak, K. M., Garcia-Beltran, W., et al. (2017) · Nature Genetics · doi:10.1038/ng.3741 · Cited by 333
Cellular Networks Involved in the Influenza Virus Life Cycle
Watanabe, T., Watanabe, S., & Kawaoka, Y. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.05.008 · Cited by 321
Viral calciomics: Interplays between Ca2+ and virus
Zhou, Y., Frey, T. K., & Yang, J. J. (2009) · Cell Calcium · doi:10.1016/j.ceca.2009.05.005 · Cited by 313
Different anti-HCV profiles of statins and their potential for combination therapy with interferon
Ikeda, M., Abe, K.-I., Yamada, M., Dansako, H., Naka, K., & Kato, N. (2006) · Hepatology · doi:10.1002/hep.21232 · Cited by 313
Creation of genomic methylation patterns
Bestor, T. H., & Tycko, B. (1996) · Nature Genetics · doi:10.1038/ng0496-363 · Cited by 310
Sutter, D., & Doerfler, W. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.253 · Cited by 298
Liang, Y., Vogel, J. L., Narayanan, A., Peng, H., & Kristie, T. M. (2009) · Nature Medicine · doi:10.1038/nm.2051 · Cited by 282
(−)-Epigallocatechin- 3 -gallate is a new inhibitor of hepatitis C virus entry
Calland, N., Albecka, A., Belouzard, S., Wychowski, C., Duverlie, G., Descamps, V., Hober, D., Dubuisson, J., Rouillé, Y., & Séron, K. (2012) · Hepatology · doi:10.1002/hep.24803 · Cited by 279
Role of Lipids in Virus Replication
Lorizate, M., & Krausslich, H.-G. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004820 · Cited by 278
Discovery of a proteinaceous cellular receptor for a norovirus
Orchard, R. C., Wilen, C. B., Doench, J. G., Baldridge, M. T., McCune, B. T., Lee, Y.-C. J., Lee, S., Pruett-Miller, S. M., Nelson, C. A., Fremont, D. H., et al. (2016) · Science · doi:10.1126/science.aaf1220 · Cited by 278
Lysis Timing and Bacteriophage Fitness
Wang, I.-N. (2006) · Genetics · doi:10.1534/genetics.105.045922 · Cited by 277
Yeung, M. L., Houzet, L., Yedavalli, V. S. R. K., & Jeang, K.-T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010033 · Cited by 267
Kaul, A., Stauffer, S., Berger, C., Pertel, T., Schmitt, J., Kallis, S., Zayas Lopez, M., Lohmann, V., Luban, J., & Bartenschlager, R. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000546 · Cited by 267
Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential
Bogoyevitch, M. A., Boehm, I., Oakley, A., Ketterman, A. J., & Barr, R. K. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.016 · Cited by 266
Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis
Hoffmann, H.-H., Kunz, A., Simon, V. A., Palese, P., & Shaw, M. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101143108 · Cited by 266
Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication
Han, J., Perez, J. T., Chen, C., Li, Y., Benitez, A., Kandasamy, M., Lee, Y., Andrade, J., tenOever, B., & Manicassamy, B. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.045 · Cited by 266
Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection
Salomon, R., Hoffmann, E., & Webster, R. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705289104 · Cited by 265
Haas, D. W., Smeaton, L. M., Shafer, R. W., Robbins, G. K., Morse, G. D., Labbé, L., Wilkinson, G. R., Clifford, D. B., D’Aquila, R. T., De Gruttola, V., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/497610 · Cited by 257
Targeting Dendritic Cells with Antigen-Containing Liposomes
van Broekhoven, C. L., Parish, C. R., Demangel, C., Britton, W. J., & Altin, J. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0138 · Cited by 256
A broad-spectrum antiviral targeting entry of enveloped viruses
Wolf, M. C., Freiberg, A. N., Zhang, T., Akyol-Ataman, Z., Grock, A., Hong, P. W., Li, J., Watson, N. F., Fang, A. Q., Aguilar, H. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909587107 · Cited by 254
Tropberger, P., Mercier, A., Robinson, M., Zhong, W., Ganem, D. E., & Holdorf, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518090112 · Cited by 246
Toll-like Receptor 1 Polymorphisms Affect Innate Immune Responses and Outcomes in Sepsis
Wurfel, M. M., Gordon, A. C., Holden, T. D., Radella, F., Strout, J., Kajikawa, O., Ruzinski, J. T., Rona, G., Black, A. R., Stratton, S., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-462oc · Cited by 244 · cited 1×
“differences in structure and function of their TLR1 proteins (220).”
BackgroundGulick, R. M., Su, Z., Flexner, C., Hughes, M. D., Skolnik, P. R., Wilkin, T. J., Gross, R., Krambrink, A., Coakley, E., Greaves, W. L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/518797 · Cited by 239
Antiviral drug resistance as an adaptive process
Irwin, K. K., Renzette, N., Kowalik, T. F., & Jensen, J. D. (2016) · Virus Evolution · doi:10.1093/ve/vew014 · Cited by 235
Walsh, K. B., Teijaro, J. R., Wilker, P. R., Jatzek, A., Fremgen, D. M., Das, S. C., Watanabe, T., Hatta, M., Shinya, K., Suresh, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107024108 · Cited by 234
Antiviral Activity of Baicalein and Quercetin against the Japanese Encephalitis Virus
Johari, J., Kianmehr, A., Mustafa, M., Abubakar, S., & Zandi, K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131216785 · Cited by 233
Multiple Effects of Silymarin on the Hepatitis C Virus Lifecycle
Wagoner, J., Negash, A., Kane, O. J., Martinez, L. E., Nahmias, Y., Bourne, N., Owen, D. M., Grove, J., Brimacombe, C., McKeating, J. A., et al. (2010) · Hepatology · doi:10.1002/hep.23587 · Cited by 232
Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
Jurgeit, A., McDowell, R., Moese, S., Meldrum, E., Schwendener, R., & Greber, U. F. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002976 · Cited by 231
Epigenetic reprogramming of host genes in viral and microbial pathogenesis
Paschos, K., & Allday, M. J. (2010) · Trends in Microbiology · doi:10.1016/j.tim.2010.07.003 · Cited by 229
Tsibris, A. M. N., Korber, B., Arnaout, R., Russ, C., Lo, C.-C., Leitner, T., Gaschen, B., Theiler, J., Paredes, R., Su, Z., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005683 · Cited by 228
Dalrymple, N. A., Cimica, V., & Mackow, E. R. (2015) · mBio · doi:10.1128/mbio.00553-15 · Cited by 228
Virological and Immunological Outcomes of Coinfections
Kumar, N., Sharma, S., Barua, S., Tripathi, B. N., & Rouse, B. T. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-17 · Cited by 228
Self-citationPhase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
Emu, B., Fessel, J., Schrader, S., Kumar, P., Richmond, G., Win, S., Weinheimer, S., Marsolais, C., & Lewis, S. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1711460 · Cited by 227
Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases
Reeves, P. M., Bommarius, B., Lebeis, S., McNulty, S., Christensen, J., Swimm, A., Chahroudi, A., Chavan, R., Feinberg, M. B., Veach, D., et al. (2005) · Nature Medicine · doi:10.1038/nm1265 · Cited by 226
Bekerman, E., Neveu, G., Shulla, A., Brannan, J., Pu, S.-Y., Wang, S., Xiao, F., Barouch-Bentov, R., Bakken, R. R., Mateo, R., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89857 · Cited by 226
Differential Requirements of Rab5 and Rab7 for Endocytosis of Influenza and Other Enveloped Viruses
Sieczkarski, S. B., & Whittaker, G. R. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00090.x · Cited by 223
A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death
Ma, H., Dang, Y., Wu, Y., Jia, G., Anaya, E., Zhang, J., Abraham, S., Choi, J.-G., Shi, G., Qi, L., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.049 · Cited by 223
Bankwitz, D., Steinmann, E., Bitzegeio, J., Ciesek, S., Friesland, M., Herrmann, E. M., Zeisel, M. B., Baumert, T. F., Keck, Z., Foung, S. K. H., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02200-09 · Cited by 221
Sung, J. J. Y., Wong, M.-L., Bowden, S., Liew, C.-T., Hui, A. Y., Wong, V. W. S., Leung, N. W. Y., Locarnini, S., & Chan, H. L. Y. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.009 · Cited by 218
Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells
Ludwig, S., Pleschka, S., Planz, O., & Wolff, T. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00678.x · Cited by 207
Coulombe, F., Jaworska, J., Verway, M., Tzelepis, F., Massoud, A., Gillard, J., Wong, G., Kobinger, G., Xing, Z., Couture, C., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.013 · Cited by 206
Hong, X., Kim, E. S., & Guo, H. (2017) · Hepatology · doi:10.1002/hep.29479 · Cited by 205
Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import
Götz, V., Magar, L., Dornfeld, D., Giese, S., Pohlmann, A., Höper, D., Kong, B.-W., Jans, D. A., Beer, M., Haller, O., et al. (2016) · Scientific Reports · doi:10.1038/srep23138 · Cited by 203
Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond
Chaudhuri, S., Symons, J. A., & Deval, J. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.05.005 · Cited by 203
Fluvastatin Inhibits Hepatitis C Replication in Humans
Bader, T., Fazili, J., Madhoun, M., Aston, C., Hughes, D., Rizvi, S., Seres, K., & Hasan, M. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01876.x · Cited by 200
Zheng, D.-L., Zhang, L., Cheng, N., Xu, X., Deng, Q., Teng, X.-M., Wang, K.-S., Zhang, X., Huang, J., & Han, Z.-G. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.019 · Cited by 198
Inhibition of p38: Has the fat lady sung?
Genovese, M. C. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24264 · Cited by 192
Abedon, S. T., Hyman, P., & Thomas, C. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.12.7499-7506.2003 · Cited by 192
A CRISPR toolbox to study virus–host interactions
Puschnik, A. S., Majzoub, K., Ooi, Y. S., & Carette, J. E. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.29 · Cited by 191
Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells
Walsh, D., & Mohr, I. (2004) · Genes & Development · doi:10.1101/gad.1185304 · Cited by 189
NF-κB Signaling Differentially Regulates Influenza Virus RNA Synthesis
Kumar, N., Xin, Z.-T., Liang, Y., Ly, H., & Liang, Y. (2008) · Journal of Virology · doi:10.1128/jvi.00909-08 · Cited by 188
Self-citationReplication and Inhibitors of Enteroviruses and Parechoviruses
van der Linden, L., Wolthers, K. C., & van Kuppeveld, F. J. M. (2015) · Viruses · doi:10.3390/v7082832 · Cited by 181
Curcumin inhibits hepatitis C virus replication via suppressing the Akt‐SREBP‐1 pathway
Kim, K., Kim, K. H., Kim, H. Y., Cho, H. K., Sakamoto, N., & Cheong, J. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.12.019 · Cited by 180
Richardson, R. B., Ohlson, M. B., Eitson, J. L., Kumar, A., McDougal, M. B., Boys, I. N., Mar, K. B., De La Cruz-Rivera, P. C., Douglas, C., Konopka, G., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0244-1 · Cited by 179
Yang, S., Xu, M., Lee, E. M., Gorshkov, K., Shiryaev, S. A., He, S., Sun, W., Cheng, Y.-S., Hu, X., Tharappel, A. M., et al. (2018) · Cell Discovery · doi:10.1038/s41421-018-0034-1 · Cited by 177
The Role of IL-10 in Regulating Immunity to Persistent Viral Infections
Wilson, E. B., & Brooks, D. G. (2010) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2010_96 · Cited by 176
Fofana, I., Krieger, S. E., Grunert, F., Glauben, S., Xiao, F., Fafi–Kremer, S., Soulier, E., Royer, C., Thumann, C., Mee, C. J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.073 · Cited by 176
Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection
Lieberman-Blum, S. S., Fung, H. B., & Bandres, J. C. (2008) · Clinical Therapeutics · doi:10.1016/s0149-2918(08)80048-3 · Cited by 176
Biopharmaceutical drug targeting to the brain
Pardridge, W. M. (2010) · Journal of Drug Targeting · doi:10.3109/10611860903548354 · Cited by 173
Glycyrrhizin inhibits influenza A virus uptake into the cell
Wolkerstorfer, A., Kurz, H., Bachhofner, N., & Szolar, O. H. J. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.04.012 · Cited by 172
Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus
Rausch, K., Hackett, B. A., Weinbren, N. L., Reeder, S. M., Sadovsky, Y., Hunter, C. A., Schultz, D. C., Coyne, C. B., & Cherry, S. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.068 · Cited by 172
Kim, K., Garner-Hamrick, P. A., Fisher, C., Lee, D., & Lambert, P. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12450-12459.2003 · Cited by 169
Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules
Marsolais, D., & Rosen, H. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2356 · Cited by 167
Epigenetics and Genetics of Viral Latency
Lieberman, P. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.04.008 · Cited by 165
A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV
OhAinle, M., Helms, L., Vermeíre, J., Roesch, F., Humes, D. G., Basom, R., Delrow, J. J., Overbaugh, J. M., & Emerman, M. (2018) · eLife · doi:10.7554/elife.39823 · Cited by 165
Pandemic Influenza: A Potential Role for Statins in Treatment and Prophylaxis
Fedson, D. S. (2006) · Clinical Infectious Diseases · doi:10.1086/505116 · Cited by 164
Role of MAPK/MNK1 signaling in virus replication
Kumar, R., Khandelwal, N., Thachamvally, R., Tripathi, B. N., Barua, S., Kashyap, S. K., Maherchandani, S., & Kumar, N. (2018) · Virus Research · doi:10.1016/j.virusres.2018.05.028 · Cited by 164
Self-citationAdherence and drug resistance: predictions for therapy outcome
Wahl, L. M., & Nowak, M. A. (2000) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2000.1079 · Cited by 160
A diversity of SERCA Ca2+ pump inhibitors
Michelangeli, F., & East, J. M. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390789 · Cited by 160
Griffithsin Has Antiviral Activity against Hepatitis C Virus
Meuleman, P., Albecka, A., Belouzard, S., Vercauteren, K., Verhoye, L., Wychowski, C., Leroux-Roels, G., Palmer, K. E., & Dubuisson, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-11 · Cited by 160
Catanese, M. T., Graziani, R., von Hahn, T., Moreau, M., Huby, T., Paonessa, G., Santini, C., Luzzago, A., Rice, C. M., Cortese, R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00193-07 · Cited by 160
AXL-Mediated Productive Infection of Human Endothelial Cells by Zika Virus
Liu, S., DeLalio, L. J., Isakson, B. E., & Wang, T. T. (2016) · Circulation Research · doi:10.1161/circresaha.116.309866 · Cited by 160
Martín-Acebes, M. A., Vázquez-Calvo, Á., & Sáiz, J. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.09.005 · Cited by 160
Protein–Protein Interactions in Virus–Host Systems
Brito, A. F., & Pinney, J. W. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01557 · Cited by 158
A Phase II Study of DAS181, a Novel Host Directed Antiviral for the Treatment of Influenza Infection
Moss, R. B., Hansen, C., Sanders, R. L., HAWLEY, S. B., Li, T., & Steigbigel, R. T. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis622 · Cited by 157
Boni, C., Vecchi, A. L., Rossi, M., Laccabue, D., Giuberti, T., Alfieri, A., Lampertico, P., Grossi, G., Facchetti, F., Brunetto, M. R., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.030 · Cited by 157
Liang, Y., Quenelle, D. C., Vogel, J. L., Mascaró, C., Ortega, A., & Kristie, T. M. (2013) · mBio · doi:10.1128/mbio.00558-12 · Cited by 156
Cytokine storms in infectious diseases
Teijaro, J. R. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0640-2 · Cited by 154
Snapshots: Chromatin control of viral infection
Knipe, D. M., Lieberman, P. M., Jung, J. U., McBride, A. A., Morris, K. V., Ott, M., Margolis, D. M., Nieto, A., Nevels, M. M., Parks, R. J., et al. (2012) · Virology · doi:10.1016/j.virol.2012.09.023 · Cited by 153
Epigenetic impact of infection on carcinogenesis: mechanisms and applications
Hattori, N., & Ushijima, T. (2016) · Genome Medicine · doi:10.1186/s13073-016-0267-2 · Cited by 152
Cytosine methylation alters DNA mechanical properties
Severin, P. M. D., Zou, X., Gaub, H. E., & Schulten, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr578 · Cited by 146
Selection for bacteriophage latent period length by bacterial density: A theoretical examination
Abedon, S. T. (1989) · Microbial Ecology · doi:10.1007/bf02030117 · Cited by 145
van der Schaar, H. M., van der Linden, L., Lanke, K. H. W., Strating, J. R. P. M., Pürstinger, G., de Vries, E., de Haan, C. A. M., Neyts, J. H., & van Kuppeveld, F. J. M. (2012) · Cell Research · doi:10.1038/cr.2012.129 · Cited by 143
Ashkar, A. A., Yao, X.-D., Gill, N., Sajic, D., Patrick, A., & Rosenthal, K. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/425079 · Cited by 141
A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor
Heaton, B. E., Kennedy, E. M., Dumm, R. E., Harding, A. T., Sacco, M. T., Sachs, D. M., & Heaton, N. S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.060 · Cited by 141
HIV-1 entry inhibitors: recent development and clinical use
Henrich, T. J., & Kuritzkes, D. R. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.12.002 · Cited by 140
Gaudieri, S., Rauch, A., Pfafferott, K. J., Barnes, E. J., Cheng, W., McCaughan, G. W., Shackel, N. A., Jeffrey, G. P., Mollison, L. C., Baker, R. I., et al. (2008) · Hepatology · doi:10.1002/hep.22773 · Cited by 140
Haviernik, J., Štefánik, M., Fojtíková, M., Kali, S., Tordo, N., Rudolf, I., Hubálek, Z., Eyer, L., & Růžek, D. (2018) · Viruses · doi:10.3390/v10040184 · Cited by 140
Yang, H., Kim, S.-K., Kim, M., Reche, P. A., Morehead, T. J., Damon, I. K., Welsh, R. M., & Reinherz, E. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523220 · Cited by 139
Epigenetic Silencing of Interferon-κ in Human Papillomavirus Type 16–Positive Cells
Rincón‐Orozco, B., Halec, G., Rosenberger, S., Muschik, D., Nindl, I., Bachmann, A., Ritter, T. M., Dondog, B., Ly, R., Bosch, F. X., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0550 · Cited by 138
The Human Kinome and Kinase Inhibition
Duong‐Ly, K. C., & Peterson, J. R. (2013) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0209s60 · Cited by 137
TESTING OPTIMALITY WITH EXPERIMENTAL EVOLUTION: LYSIS TIME IN A BACTERIOPHAGE
Heineman, R. H., & Bull, J. J. (2007) · Evolution · doi:10.1111/j.1558-5646.2007.00132.x · Cited by 136
Bitzegeio, J., Bankwitz, D., Hueging, K., Haid, S., Brohm, C., Zeisel, M. B., Herrmann, E. M., Iken, M., Ott, M., Baumert, T. F., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000978 · Cited by 135
Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm
Younan, P. M., Iampietro, M., Nishida, A., Ramanathan, P., Santos, R. I., Dutta, M., Lubaki, N. M., Koup, R. A., Katze, M. G., & Bukreyev, A. A. (2017) · mBio · doi:10.1128/mbio.00845-17 · Cited by 135
Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity
Goulet, M.-L., Olagnier, D. P., Xu, Z.-Y., Paz, S., Belgnaoui, S. M., Lafferty, E. I., Janelle, V., Arguello, M., Paquet, M., Ghneim, K., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003298 · Cited by 134
Macropinocytotic Uptake and Infection of Human Epithelial Cells with Species B2 Adenovirus Type 35
Kälin, S., Amstutz, B., Gastaldelli, M., Wolfrum, N., Boucke, K., Havenga, M. J. E., DiGennaro, F., Liska, N., Hemmi, S., & Greber, U. F. (2010) · Journal of Virology · doi:10.1128/jvi.02494-09 · Cited by 134
MEK inhibition impairs influenza B virus propagation without emergence of resistant variants
Ludwig, S., Wolff, T., Ehrhardt, C., Wurzer, W. J., Reinhardt, J., Planz, O., & Pleschka, S. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00108-5 · Cited by 133
Cicchini, L., Westrich, J. A., Xu, T., Vermeer, D. W., Berger, J., Clambey, E. T., Lee, D., Song, J. I., Lambert, P. F., Greer, R. O., et al. (2016) · mBio · doi:10.1128/mbio.00270-16 · Cited by 133
A novel orally available small molecule that inhibits hepatitis B virus expression
Mueller, H., Wildum, S., Luangsay, S., Walther, J., Lopez, A., Tropberger, P., Ottaviani, G., Lu, W., Parrott, N. J., Zhang, J. D., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.014 · Cited by 133
Walsh, D., Perez, C., Notary, J., & Mohr, I. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8057-8064.2005 · Cited by 131
Receptor Tyrosine Kinase Inhibitors Block Multiple Steps of Influenza A Virus Replication
Kumar, N., Liang, Y., Parslow, T. G., & Liang, Y. (2011) · Journal of Virology · doi:10.1128/jvi.01969-10 · Cited by 131
Self-citationXia, Y., & Liang, T. J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.057 · Cited by 131
Influenza virus and cell signaling pathways
Gaur, P., Munjhal, A., & Lal, S. K. (2011) · Medical Science Monitor · doi:10.12659/msm.881801 · Cited by 127
Murata, T., Kondo, Y., Sugimoto, A., Kawashima, D., Saito, S., Isomura, H., Kanda, T., & Tsurumi, T. (2012) · Journal of Virology · doi:10.1128/jvi.06768-11 · Cited by 127
Trial Watch: Immunostimulatory cytokines
Vacchelli, E., Galluzzi, L., Eggermont, A. M. M., Galon, J., Tartour, É., Zitvogel, L., & Kroemer, G. (2012) · OncoImmunology · doi:10.4161/onci.20459 · Cited by 126
Establishment of de novo DNA methylation patterns
Tóth, M., Müller, U., & Doerfler, W. (1990) · Journal of Molecular Biology · doi:10.1016/0022-2836(90)90285-t · Cited by 124
Pizzorno, A., Padey, B., Terrier, O., & Rosa-Calatrava, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00531 · Cited by 122 · cited 1×
“multiple host factors and pathways that are supportive of virus replication (299, 300).”
BackgroundDutta, K., Ghosh, D., & Basu, A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9158-2 · Cited by 122
Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets
Rojas, Á., Campo, J. A. D., Clément, S., Lemasson, M., García-Valdecasas, M., Gil‐Gómez, A., Ranchal, I., Bartosch, B., Bautista, J., Rosenberg, A. R., et al. (2016) · Scientific Reports · doi:10.1038/srep31777 · Cited by 122
Epigenetic regulation of human papillomavirus transcription in the productive virus life cycle
Burley, M., Roberts, S., & Parish, J. L. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-019-00773-0 · Cited by 121
A review on current status of antiviral siRNA
Qureshi, A., Tantray, V. G., Kirmani, A. R., & Ahangar, A. G. (2018) · Reviews in Medical Virology · doi:10.1002/rmv.1976 · Cited by 120
Role of the Innate Cytokine Storm Induced by the Influenza A Virus
Gu, Y., Hsu, A., Pang, Z., Pan, H., Zuo, X., Wang, G., Zheng, J., & Wang, F. (2019) · Viral Immunology · doi:10.1089/vim.2019.0032 · Cited by 119
Trimethylation of Histone H3 Lysine 4 by Set1 in the Lytic Infection of Human Herpes Simplex Virus 1
Huang, J. L., Kent, J. R., Placek, B. J., Whelan, K. A., Hollow, C. M., Zeng, P.-Y., Fraser, N. W., & Berger, S. L. (2006) · Journal of Virology · doi:10.1128/jvi.00169-06 · Cited by 118
Arora, P., Kim, E. O., Jung, J. K., & Jang, K. L. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.033 · Cited by 117
Zhang, W., Qiao, H., Lv, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110429 · Cited by 117
Influenza Virus Infections and Cellular Kinases
Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019) · Viruses · doi:10.3390/v11020171 · Cited by 117
Paeshuyse, J., Dallmeier, K., & Neyts, J. H. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.030 · Cited by 116
MEK-Specific Inhibitor U0126 Blocks Spread of Borna Disease Virus in Cultured Cells
Planz, O., Pleschka, S., & Ludwig, S. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4871-4877.2001 · Cited by 116
Perwitasari, O., Johnson, S. K., Yan, X., Howerth, E. W., Shacham, S., Landesman, Y., Baloglu, E., McCauley, D., Tamir, S., Tompkins, S. M., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01774-14 · Cited by 115
Virus-host interactomics: new insights and opportunities for antiviral drug discovery
de Chassey, B., Meyniel‐Schicklin, L., Vonderscher, J., André, P., & Lotteau, V. (2014) · Genome Medicine · doi:10.1186/s13073-014-0115-1 · Cited by 115
Zeisel, M., Lupberger, J., Fofana, I., & Baumert, T. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.022 · Cited by 114
Stoop, J. N., Molen, R. G. V. D., Kuipers, E. J., Kusters, J. G., & Janssen, H. L. A. (2006) · Virology · doi:10.1016/j.virol.2006.11.018 · Cited by 113
Curing a viral infection by targeting the host: The example of cyclophilin inhibitors
Lin, K. W., & Gallay, P. A. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.020 · Cited by 113
Sharma, S., Sundararajan, A., Suryawanshi, A. S., Kumar, N., Veiga‐Parga, T., Kuchroo, V. K., Thomas, P. G., Sangster, M. Y., & Rouse, B. T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107087108 · Cited by 112
Self-citation
Cited by
An Overview of the Recent Advances in Antimicrobial Resistance
Oliveira, M., Antunes, W., Mota, S., Madureira-Carvalho, Á., Dinis-Oliveira, R. J., & Dias da Silva, D. (2024) · Microorganisms · doi:10.3390/microorganisms12091920 · Cited by 285
Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A Review
Ribeiro, A. I., Dias, A. M., & Zille, A. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c03891 · Cited by 276
Lawrenz, J., Wettstein, L., Rodríguez Alfonso, A., Nchioua, R., von Maltitz, P., Albers, D. P. J., Zech, F., Vandeput, J., Naesens, L., Fois, G., et al. (2025) · Advanced Science · doi:10.1002/advs.202506430 · Cited by 8
Metadata
- Authors
- Kumar, N., Sharma, S., Kumar, R., Tripathi, B. N., Barua, S., Ly, H., & Rouse, B. T.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2020-06-17
- Volume
- 33
- Issue
- 3
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W3024562929
- Cited by
- 271
- References
- 409
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.